Demonstration of cellular and humoral immunity to transplantable carcinomas derived from the respiratory tract of rats
- PMID: 340026
Demonstration of cellular and humoral immunity to transplantable carcinomas derived from the respiratory tract of rats
Abstract
Previous studies with respiratory tract tumors in mice have suggested that such tumors are not immunogenic or are only weakly so. To determine whether this is a general characteristic of neoplasias found in the airways of rodents, we investigated seven transplantable carcinomas in rats, six of which originated from tracheal epithelium and one of which orginated from the distal lung. These carcinomas were all of the squamous type and were induced by three different carcinogenic polycyclic hydrocarbons. All of the tumors were shown to be immunogenic, capable of mobilizing cellular and humoral immune responses in isogenic hosts upon immunization. This was demonstrated by induction of transplantation resistance, by Winn's neutralization test, and by the detection of antibodies in the sera of tumor-immune hosts by two independent methods (antibody-dependent cytotoxicity and antibody-binding test). The degree of immunogenicity varied among the tumor lines. The most metastatic tumor was clearly the least immunogenic. The relationship between carcinogenic insult and immunogenicity, as well as the possible nature of the tumor-associated antigens involved, is discussed.
Similar articles
-
Demonstration of cross-reacting tumor rejection antigens in chemically induced respiratory tract carcinomas in rats.Cancer Res. 1977 Nov;37(11):4059-63. Cancer Res. 1977. PMID: 71203
-
Increase in immunogenicity with concomitant loss of tumorigenicity of respiratory tract carcinomas during in vitro culture.Cancer Res. 1979 Jul;39(7 Pt 1):2466-70. Cancer Res. 1979. PMID: 87265
-
Studies on a weakly immunogenic squamous cell carcinoma of the rat prostate.Invest Urol. 1980 Mar;17(5):419-24. Invest Urol. 1980. PMID: 7358506
-
Nutrition and tumor immunity: divergent effects of antitumor antibody.Cancer Res. 1975 Nov;35(11 Pt. 2):3317-9. Cancer Res. 1975. PMID: 1104143 Review.
-
[Immunology and cancer].Schweiz Med Wochenschr. 1973 Sep 8;103(36):1249-52. Schweiz Med Wochenschr. 1973. PMID: 4584090 Review. German. No abstract available.
Cited by
-
Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.Yale J Biol Med. 1981 Sep-Oct;54(5):367-79. Yale J Biol Med. 1981. PMID: 7039148 Free PMC article. Clinical Trial.
-
Syngeneic immune response to rat tracheal epithelial cells transformed in vitro by N-methyl-N-nitro-N-nitrosoguanidine.Br J Cancer. 1981 Aug;44(2):247-57. doi: 10.1038/bjc.1981.176. Br J Cancer. 1981. PMID: 7272190 Free PMC article.
-
Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells.PLoS One. 2012;7(1):e29728. doi: 10.1371/journal.pone.0029728. Epub 2012 Jan 17. PLoS One. 2012. PMID: 22272243 Free PMC article.
-
Candidate proteins interacting with cytoskeleton in cells from the basal airway epithelium in vitro.Front Mol Biosci. 2024 Jul 30;11:1423503. doi: 10.3389/fmolb.2024.1423503. eCollection 2024. Front Mol Biosci. 2024. PMID: 39139811 Free PMC article.